Oxypertine in combination with imipramine: a controlled trial
- PMID: 23973
- DOI: 10.1177/030006057800600102
Oxypertine in combination with imipramine: a controlled trial
Abstract
A method for the controlled assessment of two agents for possible interaction in the treatment of endogenous depression is described. This consisted of dose-ranging the supplementary agent (oxypertine 30 mg and 60 mg daily or matching placebo) during Week 2 to Week 6 having established all patients on a therapeutic dose of imipramine during Week 1. The reported enhancement of imipramine by oxypertine was not confirmed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
